Opdualag nivolumab 240 mg and relatlimab 80 mg per 20 mL (12 mg and 4 mg per mL) vial Images

Generic Name: nivolumab/relatlimab

This medication has been identified as Opdualag nivolumab 240 mg and relatlimab 80 mg per 20 mL (12 mg and 4 mg per mL) vial. It is supplied by Bristol-Myers Squibb Company.

Opdualag is used in the treatment of Melanoma and belongs to the drug class antineoplastic combinations. Opdualag nivolumab 240 mg and relatlimab 80 mg per 20 mL (12 mg and 4 mg per mL) vial is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Opdualag

Generic Name: nivolumab/relatlimab
Strength: nivolumab 240 mg and relatlimab 80 mg per 20 mL (12 mg and 4 mg per mL) vial
Availability: Prescription only
Drug Class: Antineoplastic combinations
CSA Schedule: Not a controlled drug
Labeler / Supplier: Bristol-Myers Squibb Company
National Drug Code (NDC): 00003-7125